The present invention provides an improved process for the manufacture (R)-6-hydroxy-8-[1-hydroxy-2-[2-(4-methoxyphenyl)-1,1-dimethyl-ethylamino-ethyl]-2H-1,4-benzoxazin-3(4H)-one, in high purity and high yield, through the use of 1,1-dimethyl-2-(4-methoxyphenyl)ethyl amine L-tartrate salt, 1,1-dimethyl-2-(4-methoxyphenyl)ethyl amine maletate salt or the camphorsulfonate salt of intermediate (4). The invention also relates to said salts, to processes for preparing them and to their use for the manufacture of (R)-6-hydroxy-8-[1-hydroxy-2-[2-(4-methoxyphenyl)-1,1-dimethyl-ethylamino-ethyl]-2H-1,4-benzoxazin-3(4H)-one or a pharmaceutically acceptable salt thereof.
本发明提供了一种高纯度、高收率生产(R)-6-羟基-8-[1-羟基-2-[2-(4-
甲氧基苯基)-
1,1-二甲基-乙基
氨基-乙基]-2H-1,4-苯并恶嗪-3(4H)-酮的改进工艺、通过使用中间体 (4) 的
1,1-二甲基-2-(4-
甲氧基苯基)
乙胺 L-酒石酸盐、
1,1-二甲基-2-(4-
甲氧基苯基)
乙胺苹果酸盐或
樟脑磺酸盐。本发明还涉及上述盐类、制备它们的工艺及其用于制造(R)-6-羟基-8-[1-羟基-2-[2-(4-
甲氧基苯基)-
1,1-二甲基-乙基
氨基-乙基]-2H-1,4-苯并恶嗪-3(4H)-酮或其药学上可接受的盐。